NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis
Article in Cancer Letters (April 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in Cancer Letters (April 2024)
Article in Biochemical Pharmacology (April 2024)
Article in Journal of Cellular and Molecular Medicine (March 2024)